Companies
RNS
Signals
Macro
AI Chat
Research
Indices
Ticker TV
Events
Commodities
Currencies

⌘K

Developer Portal News Services

Renalytix PLC (RNLXY) Share Price & Analysis | Ticker

/Equities/AIMX/RNLXY

Secondary share class. The ordinary shares trade as RENX (Renalytix PLC). Director, financial and RNS data shown here are for the issuer.

Overview Share Price RNS Trades Short Interest Directors Holdings

Renalytix PLC

/Equities/AIMX/RNLXY

Secondary share class. The ordinary shares trade as RENX (Renalytix PLC). Director, financial and RNS data shown here are for the issuer.

Overview Share Price RNS Trades Short Interest Directors Holdings

Renalytix PLC

Loading price data...

--

--

Price Chart

Open: 1.85
High: 1.98
Low: 1.97
Close: 1.98
Change: -0.05 (-2.70%)
Volume: 1,341,152

Recent RNS announcements

29 May 2026	16:24:27	Holding(s) in Company
27 May 2026	11:20:36	Holding(s) in Company
18 May 2026	15:52:13	Holding(s) in Company
5 May 2026	15:26:57	Holding(s) in Company
5 May 2026	09:39:40	Holding(s) in Company

Annual Reports

7 Jan 2025	Annual Report and Accounts (to 2024-06-30)
16 Jan 2024	Annual Report and Accounts (to 2023-06-30)
30 Dec 2022	Annual Report and Accounts (to 2022-06-30)

Directors (11)

JB

Julian BainesChairman

–

JM

James McCulloughCEO

–

EL

Erik LiumNon-Executive Director

–

CM

Christopher MillsNon-Executive Director

–

CC

Catherine CosteNon-Executive Director

–

Company details

Industry: Health Care
Sector: Health Care
LEI: 213800NTOH3FK3WER551
Region: Europe
Admission date: 6 Nov 2018
Website: www.renalytix.com

Shares details

Shares in issue: 333,637,612
Total Voting Rights: 189,933,286

Last updated: 12 June 2026

Instrument details

Loading price data...

--

--

Price Chart

Open: 1.85
High: 1.98
Low: 1.97
Close: 1.98
Change: -0.05 (-2.70%)
Volume: 1,341,152

Recent RNS announcements

29 May 2026	16:24:27	Holding(s) in Company
27 May 2026	11:20:36	Holding(s) in Company
18 May 2026	15:52:13	Holding(s) in Company
5 May 2026	15:26:57	Holding(s) in Company
5 May 2026	09:39:40	Holding(s) in Company

Annual Reports

7 Jan 2025	Annual Report and Accounts (to 2024-06-30)
16 Jan 2024	Annual Report and Accounts (to 2023-06-30)
30 Dec 2022	Annual Report and Accounts (to 2022-06-30)

Directors (11)

JB

Julian BainesChairman

–

JM

James McCulloughCEO

–

EL

Erik LiumNon-Executive Director

–

CM

Christopher MillsNon-Executive Director

–

CC

Catherine CosteNon-Executive Director

–

Company details

Industry: Health Care
Sector: Health Care
LEI: 213800NTOH3FK3WER551
Region: Europe
Admission date: 6 Nov 2018
Website: www.renalytix.com

Shares details

Shares in issue: 333,637,612
Total Voting Rights: 189,933,286

Last updated: 12 June 2026

Instrument details

ISIN

GB00BYWL4Y04

Exchange

Market

Aim

Market Segment

ASX1

Market Sector

AIMP

ISIN

GB00BYWL4Y04

Exchange

Market

Aim

Market Segment

ASX1

Market Sector

AIMP

Share Price1.98p

Day Change-0.05p(-2.70%)

Market Cap£6.6m

12 Jun 14:43

Market closed

Share Price1.98p

Day Change-0.05p(-2.70%)

Market Cap£6.6m

12 Jun 14:43

Market closed